follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeAuthorsAnkit Singhania

      Articles by Ankit Singhania

      Ankit Singhania
      Based in India, Ankit is a financial content writer and stock market analyst. He has worked for almost a decade on several financial projects related to the stock market news, fundamental research and technical analysis for several websites. He obtained his Masters Degree In finance (MS – finance) from ICFAI. Currently, he serves as a financial consultant and technical analyst at Tradersinsights.com.
      CCXI stock
      Biotechnology

      CCXI Stock Rockets 325% on Impressive Topline Data for Avacopan

      Nov 26 Ankit Singhania
      CCXI stock is witnessing its biggest one-day gain after ChemoCentryx Inc (NASDAQ:CCXI) announced positive topline data from its pivotal Phase III ADVOCATE trial for avacopan. Dream Run for CCXI Stock When a pharmaceutical company announces ... [Read]
      ADMP stock
      Drug Manufacturers

      ADMP Stock Falls 50%: FDA Rejects Opioid Overdose Treatment Zimhi

      Nov 25 Ankit Singhania
      ADMP is one of the biggest losers in the health sector on Monday after Adamis Pharmaceuticals Corp (NASDAQ:ADMP) said that the US Food and Drug Administration did not approve its opioid overdose treatment, Zimhi. Major ... [Read]
      WKHS stock
      Autos

      WKHS Stock Soars After Reaching a $41 Million Financing Deal

      Nov 22 Ankit Singhania
      WKHS stock is moving up sharply on Friday after Workhorse Group Inc (NASDAQ:WKHS) said that it has entered into a $41 million financing agreement with an institutional lender. Major Boost One of the companies that ... [Read]
      HEPA stock
      Biotechnology

      HEPA Stock Flies 50% After Impressive Data for CRV431

      Nov 21 Ankit Singhania
      Positive trial data can have a highly positive effect on the stock of a pharmaceutical company, and that is what happened with HEPA stock today. Immediate Bullish News In an important development today, Hepion Pharmaceuticals ... [Read]
      ARAV stock
      Biotechnology

      ARAV Stock Hits Multi-Year High on Solid Phase 1 Data for AVB-500

      Nov 20 Ankit Singhania
      ARAV stock is hitting a multi-year high after Aravive Inc (NASDAQ:ARAV) reported positive data from a Phase 1b clinical trial evaluating its lead candidate AVB-500 in platinum-resistant ovarian cancer. Impressive Data This morning, the company ... [Read]
      MYOV stock
      Biotechnology

      MYOV Stock Soars 153% on Positive Relugolix Data

      Nov 19 Ankit Singhania
      When it comes to pharmaceutical or biotech stocks, positive news with regards to any product that is in development almost always leads to a rise in the stock price. That is exactly what happened with ... [Read]
      KRTX stock
      Biotechnology

      KRTX Stock Hits New High, Up 228% After KarXT Data

      Nov 18 Ankit Singhania
      KRTX stock is having its biggest one-day gain and has hit a new high after Karuna Therapeutics Inc (NASDAQ:KRTX) announced positive results from a Phase 2 clinical trial evaluating KarXT in schizophrenic patients with acute ... [Read]
      JCP stock
      Retail

      JCP Stock Surges 10% on Small Q3 Loss, Sees Lower Sales Going Forward

      Nov 15 Ankit Singhania
      JCP stock is moving higher this morning after JC Penney Company Inc (NYSE:JCP) reported a narrower-than-expected loss for the third quarter. Lower Losses The iconic department store chain JC Penney has been in all sorts ... [Read]
      PLUG stock
      Industrial Products

      PLUG Stock Hits New 52-Week High on Growing Optimism

      Nov 14 Ankit Singhania
      Fuel cell firm Plug Power Inc (NASDAQ:PLUG) has made a lot of progress in 2019 so far, and naturally, there was a lot of expectation with regards to its third-quarter financial results. PLUG stock is ... [Read]
      CHK stock
      Oil & Gas

      CHK Stock Slumps 50% Since Earnings: What to Expect Now?

      Nov 13 Ankit Singhania
      The year has proven to be a volatile one for energy companies and their stocks, but the situation with CHK stock in recent days has been particularly brutal. Over the course of the past few ... [Read]

      Posts pagination

      « 1 … 11 12 13 … 27 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE ChemoCentryx Email Alerts
      Get FREE ChemoCentryx Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x